TCL Archive FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion October 9, 1987
TCL Archive IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel November 26, 1999
TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010